The Institute of Cancer Research is a public research institute and a constituent college of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.
The QIMR Berghofer Medical Research Institute is an Australian medical research institute located in Herston, Brisbane, in the state of Queensland. QIMR was established in 1945 by the Government of Queensland through the enactment of the Queensland Institute of Medical Research Act 1945 (Qld). Previously known as the Queensland Institute of Medical Research (QIMR), the original purpose of the Institute was to further the study of tropical diseases in North Queensland. The current Director is Professor Frank Gannon. The institute is a registered charity.
Vancouver General Hospital is a medical facility located in Vancouver, British Columbia. It is the largest facility in the Vancouver Hospital and Health Sciences Centre (VHHSC) group of medical facilities. VGH is Canada's second largest hospital, after The Ottawa Hospital.
UBC Hospital is a health care facility located on the University Endowment Lands in Vancouver, British Columbia, Canada. It opened in 1968, and is now operated by Vancouver Coastal Health.
Vancouver Hospital and Health Sciences Centre (VHHSC) is an acute care hospital affiliated with the University of British Columbia and located in Vancouver, British Columbia. The VHHSC is the second largest hospital in Canada, with 1,900 beds and nearly 116,000 patients each year. VHHSC employs 9500 staff and utilizes 1000 volunteers. As of 2005, the hospital's annual budget is $463 million. It is managed by Vancouver Coastal Health.
Vancouver Coastal Health (VCH) is a regional health authority providing direct and contracted health services including primary, secondary, tertiary and quaternary care, home and community care, mental health services, population and preventive health and addictions services in part of Greater Vancouver and the Coast Garibaldi area.
Expenditures by Canadian universities on scientific research and development accounted for about 40% of all spending on scientific research and development in Canada in 2006.
David F. Hardwick's MD, FRCPC, FCAP career focused on the field of paediatric pathology. Hardwick was involved with The University of British Columbia (UBC) for more than sixty years as both a student and professor, and is a Professor Emeritus. His research included the first description of histopathologic implications of differential survival of Wilms' Tumors to pathogenesis of L-methionine toxicity and administrative/management research.
Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia and Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).
The Melanoma Institute Australia is a non-profit organization based at the Poche Centre in North Sydney, Australia which focuses on prevention of and cure for melanoma through research, treatment and education programs. The institute is affiliated with The University of Sydney and St Vincent’s and Mater Health Sydney. It relies on funding from individuals, organisations and government grants.
Gary Ho is a Taiwanese-born Canadian businessman, humanitarian, and philanthropist. He is a real estate developer and the CEO of the Canadian chapter of the Tzu Chi Foundation, which he established in 1992.
The Centre for Menstrual Cycle and Ovulation Research (CeMCOR) is a health research centre in Vancouver. According to the University of British Columbia, CeMCOR is the only centre in the world that focuses on ovulation and the causes and consequences of ovulation disturbances. CeMCOR is known for research on progesterone-only therapy for menopausal hot flushes, research on perimenopause as distinct from menopause, and for a focus on women's perspectives and self-knowledge.
Rosetta Martiniello-Wilks is an Australian cancer researcher and the current president of the Australasian Gene and Cell Therapy Society. She is a senior lecturer in the School of Medical and Molecular Biosciences at the University of Technology Sydney (UTS) in Ultimo, Sydney, Australia. Martiniello-Wilks is a core member of the Centre for Health Technologies at UTS and head of the Translational Cancer Research Group in the School of Medical and Molecular Biosciences, Faculty of Science, UTS.
Professor Colleen Nelson is a scientist in prostate cancer research. Professor Nelson founded and directs the Australian Prostate Cancer Research Centre - Queensland (APCRC-Q). The Centre, based at the Translational Research Institute and the Princess Alexandra Hospital, spans the spectrum of discovery of new therapeutic targets and their preclinical and clinical development. Professor Nelson is also Chair of Prostate Cancer Research at Queensland University of Technology (QUT).
The Translational Research Institute (TRI) is Australia’s first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.
Founded in 1965, the foundation's key role is to support the leading medical and health research conducted at The Queen Elizabeth Hospital and the Basil Hetzel Institute for Translational Health Research to improve the health of the South Australian community.
Brisbane Diamantina Health Partners (BDHP) is the first Advanced Health Research Translation Centre in Queensland, Australia. The organisation’s purpose is to strengthen the linkages between healthcare, research and education in order to deliver better health outcomes for the community. By encouraging and supporting collaboration, BDHP assists the translation and integration of cutting-edge research and innovation into healthcare delivery.
Dr. Martin Gleave is a Canadian surgeon and cancer researcher who was appointed to the Order of Canada in 2018.
Suzanne Kathleen Chambers, is a Professor and Dean of the Faculty of Health at Sydney's University of Technology. She specialises in psycho-oncology, and has received Queen's Birthday honours. Chambers has worked on psycho-oncology, prostate cancer, health economics and psychological interventions including the distress and adjustments after cancer.
Robert Hung-Ngai Ho is a Chinese Canadian-American philanthropist and former journalist.
